| Literature DB >> 20080955 |
Amy Hansen1, Stephen Henderson, Dimitrios Lagos, Leonid Nikitenko, Eve Coulter, Sinead Roberts, Fiona Gratrix, Karlie Plaisance, Rolf Renne, Mark Bower, Paul Kellam, Chris Boshoff.
Abstract
Kaposi sarcoma herpesvirus (KSHV) induces transcriptional reprogramming of endothelial cells. In particular, KSHV-infected lymphatic endothelial cells (LECs) show an up-regulation of genes associated with blood vessel endothelial cells (BECs). Consequently, KSHV-infected tumor cells in Kaposi sarcoma are poorly differentiated endothelial cells, expressing markers of both LECs and BECs. MicroRNAs (miRNAs) are short noncoding RNA molecules that act post-transcriptionally to negatively regulate gene expression. Here we validate expression of the KSHV-encoded miRNAs in Kaposi sarcoma lesions and demonstrate that these miRNAs contribute to viral-induced reprogramming by silencing the cellular transcription factor MAF (musculoaponeurotic fibrosarcoma oncogene homolog). MAF is expressed in LECs but not in BECs. We identify a novel role for MAF as a transcriptional repressor, preventing expression of BEC-specific genes, thereby maintaining the differentiation status of LECs. These findings demonstrate that viral miRNAs could influence the differentiation status of infected cells, and thereby contribute to KSHV-induced oncogenesis.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20080955 PMCID: PMC2807354 DOI: 10.1101/gad.553410
Source DB: PubMed Journal: Genes Dev ISSN: 0890-9369 Impact factor: 11.361